openPR Logo
Press release

Drug Discovery Services Market - Competitive players & key drawbacks 2025 | Merck, SRI International

02-14-2019 12:45 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: TMR Research

/ PR Agency: TMR Research
Drug Discovery Services Market - Competitive players & key

Global Drug Discovery Services Market: Snapshot

The global drug discovery services market is thriving on account of the rising impetus given to research and development across several industrial. Drug discovery forms an important niche of the pharmaceutical industry, and the extensive efforts employed by researchers to invent new drug models have popularized the market. The pharmaceutical companies have become increasingly concerned about manufacturing novel drugs, and freeing the process of drug discovery from any hassles. Hence, outsourcing of drug discovery has emerged as a prominent trend amongst these companies, which has propelled demand within the market. Furthermore, the rising expenditure on research and development of new drugs for the treatment of fatal diseases and disorders has also pushed market growth. Clinical trials and analytic testing is an important standpoint to analyze the contributors to the market. One of the most pressing concerns within the medical circles is the rising instance of cancers across the globe. Scientists and researchers are undertaking key research, testing, and development initiatives in order to find permanent cures for different cancers. Hence, the market for drug discovery services is treading a positive growth path on account of the developments in oncology.

Request Sample Copy of the Report @
www.tmrresearch.com/sample/sample?flag=B&rep_id=2696

The geographical segmentation of the market reveals key segments viz. North America, Europe, Asia Pacific, Latin America, and the rest of the world. The prominence of the North American region in research and development is expected to bolster regional growth.

WuXi AppTec, Albany Molecular Research Inc., GenScript, Charles River Laboratories International, Covance, and Evotec are some of the key players with proven competency within the market. These market players are expected to engage in core research in order to come up with effective drugs and molecular compositions.

Global Drug Discovery Services Market: Overview

The key factors boosting the drug discovery services market is the increasing research and development expenditure, an increase in the number of pharmaceutical companies outsourcing their work to avoid various hassles, and an increasing demand for outsourcing clinical trials services and analytical testing. However, the market can be restricted on account of the stringent regulations which govern drug discovery. Stringent policies regarding the use of animals will also hamper the growth of this market. In addition to this the high cost involved in the discovery and development of drugs will pose a challenge for the growth of this market.

Request TOC of the Report @
www.tmrresearch.com/sample/sample?flag=T&rep_id=2696

Global Drug Discovery Services Market: Trends

Of the two types of drugs available in the market viz biologics and small molecules, the demand for small molecules is large on account of the simplicity of these drugs as well as the ease to characterize. As small molecules are well defined, they can easily enter cells, cause a person's cancer cells to die, and affect other molecules. Thus, many targeted therapies make use of small molecules. Of the key services offered such as biology service, medicinal chemistry, and drug metabolism and pharmacokinetics (DMPK), the demand for medicinal chemistry is high on account of the growing inclination of pharmaceutical companies towards outsourcing. On the basis of therapeutic area, this market may be categorised into neurology, oncology, respiratory diseases, cardiovascular diseases, and diabetes. Of these it is estimated that the oncology therapeutic area will drive maximum revenue on account of the increasing number of patients suffering from cancer.

Global Drug Discovery Services Market: Market Potential

Target selection, hit to lead identification, target validation, candidate validation, and lead optimisation are some of the processes in the drug discovery service market. Of these, the hit to lead identification process is emerging as a leading process on account of the growing research based on high throughput screening.

Global Drug Discovery Services Market: Regional Outlook

The global drug discovery services market can be segmented into Europe, North America, Latin America, Asia Pacific, and the Rest of the World. Of these, it is anticipated that North America will continue to lead in the market on account of the early adoption of advanced technologies. Asia Pacific is also expected to emerge as a key drug discovery services market in the years to come.

Read Comprehensive Overview of Report @
www.tmrresearch.com/drug-discovery-services-market

Global Drug Discovery Services Market: Competitive Landscape:

The market for drug discovery services is highly fragmented with a large number of regional and international players. Some of the players are: Thermo Fisher Scientific, Charles River Laboratories International, Albany Molecular Research Inc., Domainex, WuXi AppTec, Piramal Enterprises, GenScript, GVK Biosciences, Jubilant Biosys, Pharmaceutical Product Development, LLC (PPD), Merck, SRI International, Covance, Viva Biotech, Evotec, Selcia Limited, GE Healthcare, and Lonza.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Services Market - Competitive players & key drawbacks 2025 | Merck, SRI International here

News-ID: 1588554 • Views: 150

More Releases from TMR Research

Covid 19 Impact On, Narcolepsy Drugs Market 2018 Growth, Demands, CAGR, Sales Vo …
Global Narcolepsy Drugs Market: Overview The narcolepsy drug pipeline has been dotted with medications that can target several symptoms of neurological sleep disorder. These symptoms are characterized notably under narcolepsy type 1 and narcolepsy type 2. An array of psychostimulants have gained favor among clinicians as third-line therapy. The global narcolepsy market has made strides driven by advances adjunctive behavioral techniques. To know Untapped Opportunities in the Market https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6068 Moreover, constant development
E-prescribing Marke by 2018-2028 Profiling key players: eClinicalWorks, HealthFu …
Global E-prescribing Market: Overview The market is driven by the need for an error-free prescription process and constant government efforts towards quality and the affordable healthcare system. As per World Health Organization (WHO) member states report 2019, there is less than one doctor for per thousand populace. The uneven proportion of patient-specialist further increases the need for accurate E-prescribing arrangements. Medical prescriptions are the written directions by which doctors recommend and
Surgical Instruments Tracking Systems Market 2018 | Industry Overview, Competiti …
Surgical Instruments Tracking Systems Market: Snapshot The global surgical instruments tracking devices market is likely to be driven by the rising need for implementation of Unique Device Identification regulations by the FDA and inventory management. In addition, technological advancements coupled with increased government initiatives are likely to offer ample growth opportunities for the global surgical instruments tracking devices market. Get Exclusive PDF Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=5760 A few of the surgical
Urgent Care Apps Market 2028 Analysis & Technological Innovation by Leading Key …
Urgent Care Apps Market – Introduction The advent of m-Health or mobile health has transformed the accessibility of patient care. While m-Health operates through mobile devices such as mobile phones and other smart communication devices for healthcare information delivery, development of mobile apps has almost brought the hospital to patient rather than the conventional care-approach flow from the patient to the hospital. These factors are likely to influence urgent care apps

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning